全文获取类型
| 收费全文 | 54472篇 |
| 免费 | 4204篇 |
| 国内免费 | 1110篇 |
专业分类
| 耳鼻咽喉 | 764篇 |
| 儿科学 | 1197篇 |
| 妇产科学 | 654篇 |
| 基础医学 | 2508篇 |
| 口腔科学 | 1204篇 |
| 临床医学 | 5553篇 |
| 内科学 | 6494篇 |
| 皮肤病学 | 787篇 |
| 神经病学 | 3295篇 |
| 特种医学 | 1291篇 |
| 外国民族医学 | 1篇 |
| 外科学 | 6602篇 |
| 综合类 | 9536篇 |
| 一般理论 | 1篇 |
| 预防医学 | 4836篇 |
| 眼科学 | 748篇 |
| 药学 | 5931篇 |
| 72篇 | |
| 中国医学 | 5073篇 |
| 肿瘤学 | 3239篇 |
出版年
| 2024年 | 108篇 |
| 2023年 | 707篇 |
| 2022年 | 1651篇 |
| 2021年 | 2068篇 |
| 2020年 | 2055篇 |
| 2019年 | 2423篇 |
| 2018年 | 2367篇 |
| 2017年 | 2150篇 |
| 2016年 | 2249篇 |
| 2015年 | 2171篇 |
| 2014年 | 4607篇 |
| 2013年 | 4348篇 |
| 2012年 | 3960篇 |
| 2011年 | 4254篇 |
| 2010年 | 3645篇 |
| 2009年 | 2903篇 |
| 2008年 | 2703篇 |
| 2007年 | 2549篇 |
| 2006年 | 2110篇 |
| 2005年 | 1794篇 |
| 2004年 | 1467篇 |
| 2003年 | 1438篇 |
| 2002年 | 1093篇 |
| 2001年 | 1013篇 |
| 2000年 | 742篇 |
| 1999年 | 574篇 |
| 1998年 | 383篇 |
| 1997年 | 306篇 |
| 1996年 | 279篇 |
| 1995年 | 193篇 |
| 1994年 | 162篇 |
| 1993年 | 121篇 |
| 1992年 | 118篇 |
| 1991年 | 85篇 |
| 1990年 | 69篇 |
| 1989年 | 65篇 |
| 1988年 | 74篇 |
| 1987年 | 58篇 |
| 1986年 | 53篇 |
| 1985年 | 118篇 |
| 1984年 | 89篇 |
| 1983年 | 67篇 |
| 1982年 | 59篇 |
| 1981年 | 46篇 |
| 1980年 | 64篇 |
| 1979年 | 54篇 |
| 1978年 | 28篇 |
| 1974年 | 21篇 |
| 1973年 | 23篇 |
| 1972年 | 20篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
Ehsan Zarei Elmira Madarshahian Adeleh Nikkhah Soheila Khodakarim 《Journal of tissue viability》2019,28(2):70-74
Background and objective
Pressure ulcer (PU) is one of the important and frequent complications of hospitalization, associated with high treatment costs. The present study was conducted to determine the incidence of PU and its direct treatment costs for patients in intensive care unit (ICU) in Iran.Material and methods
In this retrospective study, medical records of 643 discharged patients from ICU of two selected hospitals were examined. The demographic and clinical data of all patients and data of resources and services usage for patients with PU were extracted through their records. Data analysis was done using logistic regression tests in SPSS 22 software. The cost of PU treatment was calculated for each grade of ulcer.Results
The findings showed that 8.9% of patients developed PU during their stay in ICU. Muscular paralysis (OR?=?5.1), length of stay in ICU (OR?=?4.0), diabetes (OR?=?3.5) age (OR?=?2.9), smoking (OR?=?2.1) and trauma (OR?=?1.4) were the most important risk factors of PU. The average cost of PU treatment varied from USD 12 for grade I PU to USD 66?834 for grade IV PUs. The total treatment costs for all studied patients with PU was estimated at USD 519?991.Conclusion
The cost of PU treatment is significant. Since the preventive measures are more cost-effective than therapeutic measures, therefore, effective preventive interventions are recommended. 相似文献2.
3.
Comparative outcomes of vascular access in patients older than 70 years with end-stage renal disease
Deokbi Hwang Sujin Park Hyung-Kee Kim Seung Huh 《Journal of vascular surgery》2019,69(4):1196-1206.e5
Objective
The advantage of arteriovenous fistulas (AVFs) in older patients requiring dialysis is controversial. We reviewed our vascular access experience in patients ≥70 years of age (older group) compared with younger patients.Methods
We analyzed consecutive patients who underwent access surgery between 2013 and 2016. Primary success (PS) and primary patency (PP) data were analyzed between the older and younger groups before and after propensity score matching of the patients' characteristics and access composition. PS was defined as the achievement of access function that was amenable to two sessions of successful cannulation without early occlusion or maturation failure requiring revision. PP was defined as the time with uninterrupted patency without intervention.Results
A total of 594 consecutive accesses were created among 563 patients, of whom 119 were allocated into each group after propensity score matching. In the whole cohort, 193 accesses (32.5%) were performed in older patients. AVFs were performed in 130 (67.4%) older patients and 293 (73.1%) younger patients. Regarding AVFs, the PS rate (83.6% in the older group vs 94.3% in the younger group; P = .001) and the overall PP at 6 and 12 months (73.1% and 57.1%, respectively, in the older group vs 86.7% and 77.7%, respectively, in the younger group; P = .009) were lower in the older group than in the younger group. However, no differences were found in the PS and PP rates for arteriovenous grafts between groups. Regarding the AVF location, the PS rate for forearm AVFs was significantly lower in the older group than in the younger group (76% vs 93%; P < .001); however, the PS rate of the upper arm was not different between the groups (94% vs 97%; P = .425). In the patients with PS, the PP rate of AVFs was similar between the two groups. In the older group with forearm AVFs, the median diameter of the radial artery was larger in the patients with PS than in the patients without PS (2.20 mm with PS vs 2.00 mm without PS; P = .008). The propensity score matching results demonstrated similar trends for the whole cohort, with lower PS (P = .042) and PP rates (P = .023) for AVF in the older group.Conclusions
The outcomes after AVF were poorer in the older group than in the younger group, which was primarily due to unsatisfactory outcomes in patients with forearm AVFs. Thus, stricter criteria, especially regarding the radial artery diameter, should be applied for forearm AVFs in older patients, and additional research is necessary to delineate the risk factors for primary failure. 相似文献4.
Katherine M. Duszynski Nicole L. Pratt John W. Lynch Jesia G. Berry Michael S. Gold 《Vaccine》2019,37(2):280-288
Objective
To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.Design
Observational nationwide cohort study.Setting
Linked population data from the Australian Childhood Immunisation Register and National Death Index.Participants
Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.Main outcome measures
Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.Results
The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.Conclusion
Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality. 相似文献5.
《Clinical gastroenterology and hepatology》2022,20(8):1776-1783.e4
- Download : Download high-res image (187KB)
- Download : Download full-size image
6.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献7.
8.
张其周 《中华临床医学杂志》2006,7(1):62-63
针对老年高血压病人的治疗，要积极采取药物和非药物治疗措施，既要保持血压稳定在正常或接近正常水平，又要最大限度地降低心脑血管病的并发率、病残率和死亡率。在临床工作中，除采取必要的药物控制血压外，帮助老年高血压患者安排好日常生活，树立正确地防治观念，养成按时作息和定时排便的习惯；合理的饮食，限制食盐量，戒烟戒酒，控制热量摄入；以及根据老年高血压病人的身体情况，选择有规律的适当运动，坚持循序渐进的锻炼：同时，要保持乐观开朗的心怀和积极健康的心态，生活要安排张弛有度，又多姿多彩，努力营造一个感情融洽，和睦相处的温馨美好的家庭环境。这些非药物治疗措施，都能取得了令人满意的效果，是治疗老年高血压病的最佳保健良方。 相似文献
9.
目的:窦道是通达组织深部的盲管性创道,时发时愈,迁延日久.是临床工作者常见的问题,治疗十分困难;为探索窦道的新的治疗途径,开展了微波治疗窦道的临床研究.方法:微波组:采用微波热机局部照射 外科常规换药治疗;根据病变部位分别选择直径为10cm或16cm的辐射器,辐射器距窦道口距离为3cm～5cm,隔1d或隔2d治疗1次,每次30 min,10次为1个疗程,微波治疗功率为70W,治疗结束观察治疗效果.对照组:按外科常规换药治疗.结果:微波组痊愈率98%,好转率2%,总有效率100%;对照组痊愈率37.5%,有效率37.5%,无效率25%,总有效率75%;结论:微波治疗窦道不愈患者具有简单、安全、方便、疗效独特等优点. 相似文献
10.
James R. Westphal 《International journal of mental health and addiction》2007,5(2):123-140
Introduction Recent reviews found problem gamblers are heterogeneous and recommended subtyping gamblers in treatment studies.
Objective Review factors (stage of change, preferred gambling activity, co-occurring disorder, and temporal instability of symptoms)
for subtyping by evaluating the evidence for their effects on gambling treatment.
Methods Literature review, evidence grading.
Results Evidence is limited that any of the reviewed factors affects gambling treatment. Substantial evidence from prospective studies
and other evidence from cross-sectional studies and the strong placebo response among pathological gamblers support the temporal
instability of gambling symptoms.
Conclusions Multiple studies are needed to develop the evidence base needed to subtype gamblers in treatment. Changes in the diagnostic
criteria of pathological gambling may be necessary, especially to specify the persistence of gambling-related symptoms. 相似文献